Trial intelligence / Profile preview

PAAS: Adjunctive Antibiotics in Periodontitis

NCT06131021Phase 3Completed

Sponsor
Rutgers University
Start
Apr 2024
Primary completion
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of amoxicillin and metronidazole in periodontitis (2 arms), sponsored by Rutgers University. Primary endpoint: Probing Depth at 6 weeks. Started Apr 2024; status: completed.

02

Drugs

amoxicillinmetronidazole
03

Conditions

periodontitis

Beyond the preview

Go deeper on NCT06131021.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06131021.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call